Zai Lab Limited (ZLAB) Stock Forecast
ZLAB analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.67 / 5 from 12 analysts
- Price target
- $33.14 average of analyst targets
- Upside to target
- +42.9% from the latest close
- Next earnings
- November 5, 2026 EPS estimate $-0.56
- 52-week range
- $16.30 – $29.15
ZLAB analyst ratings
12 analystsNumber of analysts at each rating.
ZLAB price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
ZLAB earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.56 | −$0.67 | −$0.49 | −$0.33 | −71.0% | 6 |
| Current fiscal year (2026) | −$2.20 | −$2.76 | −$1.60 | −$1.60 | −37.2% | 10 |
| Next fiscal year (2027) | −$2.11 | −$3.15 | −$1.17 | −$2.20 | +3.9% | 10 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
ZLAB revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $108.8M | $105.0M | $112.3M | −6.3% | 6 |
| Current fiscal year (2026) | $436.5M | $410.0M | $488.3M | −5.1% | 14 |
| Next fiscal year (2027) | $552.1M | $466.3M | $780.0M | +26.5% | 16 |
ZLAB EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
ZLAB revenue: reported and forecast
ZLAB EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.53 | −$0.53 | −$0.54 | −$0.58 | −$0.56 | +7.1% | 2 up · 3 down |
| Current fiscal year (2026) | −$2.16 | −$2.17 | −$2.19 | −$2.20 | −$2.20 | +1.5% | 6 up · 3 down |
| Next fiscal year (2027) | −$1.75 | −$1.75 | −$1.93 | −$2.11 | −$2.11 | +20.8% | 0 up · 9 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
ZLAB earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; ZLAB beat in 6 of 12.
What analysts expect from ZLAB
12 analysts cover Zai Lab; their consensus rating is strong buy (4.67 on a 1–5 scale, where 5 is a strong buy). The average price target is $33.14, 42.9% above the latest close of $23.19. Analysts expect earnings of −$2.20 per share for 2026, −37.2% from a year earlier. For 2027 the average estimate is −$2.11 per share on revenue of $552.1 million. Zai Lab beat the EPS estimate in 6 of the last 12 quarters.
Related: ZLAB income statement, ZLAB key metrics, ZLAB chart. See the ZLAB stock overview for the latest quote and news.
ZLAB forecast FAQ
What is Zai Lab's price target?
The average analyst price target for Zai Lab is $33.14, 42.9% above the latest close of $23.19.
Is Zai Lab a buy, hold or sell?
Of 12 analysts covering Zai Lab, 9 rate it a strong buy, 2 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Zai Lab's EPS forecast?
Analysts forecast −$2.20 per share for 2026 (range −$2.76 to −$1.60); for 2027 the estimate is −$2.11.
What is Zai Lab's revenue forecast?
The average revenue estimate for 2026 is $436.5 million, growth of −5.1%; for 2027 it is $552.1 million.
When does Zai Lab report earnings?
Zai Lab is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 before the market opens; the EPS estimate is $-0.56.
Does Zai Lab usually beat earnings estimates?
Zai Lab reported EPS at or above the analyst estimate in 6 of the last 12 quarters.